Cargando…

Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men

Previous studies have showed that men suffering from diabetes mellitus, metabolic syndrome (MetS) and obesity have a higher risk of benign prostatic hyperplasia (BPH). The present study aimed to examine the association between BPH, obesity, and features of MetS among men of the Hunan area of China....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Zhuo, Yang, Jin-Rui, Rao, Jian-Ming, Song, Wei, Zhou, Ke-Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577599/ https://www.ncbi.nlm.nih.gov/pubmed/25677137 http://dx.doi.org/10.4103/1008-682X.148081

Ejemplares similares

Influence of body mass index on Benign Prostatic Hyperplasia-related complications in patients undergoing prostatectomy
por: Mosli, Hisham A, et al.
Publicado: (2013)

Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
por: Dun, Rong-liang, et al.
Publicado: (2022)

Correlation between body mass index and prostate volume in benign prostatic hyperplasia patients undergoing holmium enucleation of the prostate surgery
por: Batai, Ken, et al.
Publicado: (2021)

Metabolic syndrome and benign prostatic hyperplasia: An update
por: Ngai, Ho-Yin, et al.
Publicado: (2017)

Age-related changes for the predictors of benign prostatic hyperplasia in Chinese men aged 40 years or older
por: Shao, Wei-Hao, et al.
Publicado: (2022)

LILRA3 Is Associated with Benign Prostatic Hyperplasia Risk in a Chinese Population
por: Jiao, Yang, et al.
Publicado: (2013)

Effects of Tamsulosin on Premature Ejaculation in Men with Benign Prostatic Hyperplasia
por: Choi, Jae Hwi, et al.
Publicado: (2014)

Relationship of oestrogen receptor alpha gene polymorphisms with risk for benign prostatic hyperplasia and prostate cancer in Chinese men
por: Han, Zihua, et al.
Publicado: (2017)

Benign Prostatic Hyperplasia
Publicado: (2015)

Ultrasonographic Intravesical Prostatic Protrusion in Men with Benign Prostatic Hyperplasia in Southwest Nigeria
por: Okedere, Tolulope Adebayo, et al.
Publicado: (2023)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

SUN-747 Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia
por: Liu, Teresa T, et al.
Publicado: (2020)

Aquablation in men with benign prostate hyperplasia: A systematic review and meta-analysis
por: Chen, David C., et al.
Publicado: (2023)

Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia
por: Huang, Jin, et al.
Publicado: (2015)

The effectiveness of reducing the daily dose of finasteride in men with benign prostatic hyperplasia
por: Sullivan, Michael J, et al.
Publicado: (2002)

Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?
por: Rył, Aleksandra, et al.
Publicado: (2015)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
por: Putra, Ida Bagus O.W., et al.
Publicado: (2016)

Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia
por: Gangkak, Goto, et al.
Publicado: (2017)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients
por: Li, Bing-Hui, et al.
Publicado: (2019)

Relationship between Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Metabolic Syndrome in Korean Men
por: Park, Yeon Won, et al.
Publicado: (2012)

Influence of metabolic syndrome on the relationship between fatty acids and the selected parameters in men with benign prostatic hyperplasia
por: Grzesiak, Katarzyna, et al.
Publicado: (2019)

Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies
por: Angalakuditi, Mallik, et al.
Publicado: (2010)

Bacteriology of Urine Specimens Obtained from Men with Symptomatic Benign Prostatic Hyperplasia
por: Agbugui, Jude Orumuah, et al.
Publicado: (2016)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
por: Abotsi, Ebenezer, et al.
Publicado: (2022)

Exophytic benign prostatic hyperplasia presenting as a polycystic pelvic mass
por: Xu, Shuang, et al.
Publicado: (2023)

Predictors of urgency improvement after Holmium laser enucleation of the prostate in men with benign prostatic hyperplasia
por: Hur, Won Sok, et al.
Publicado: (2016)

Association between the neutrophil‐to‐lymphocyte ratio and intravesical prostatic protrusion in men with benign prostatic hyperplasia
por: Chung, Mun Su, et al.
Publicado: (2019)

Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders
por: Grzesiak, Katarzyna, et al.
Publicado: (2018)

Clinical Significance of the Resistive Index of Prostatic Blood Flow According to Prostate Size in Benign Prostatic Hyperplasia
por: Kwon, Se Yun, et al.
Publicado: (2016)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Higher Body Mass Index Increases the Risk for Biopsy-Mediated Detection of Prostate Cancer in Chinese Men
por: Hu, Meng-Bo, et al.
Publicado: (2015)

Ramelteon combined with an α(1)-blocker decreases nocturia in men with benign prostatic hyperplasia
por: Kawahara, Takashi, et al.
Publicado: (2013)

Association of Functional Ability and Benign Prostatic Hyperplasia With Urinary Incontinence in Older Korean Men
por: Park, Jeongok, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_em1jm5etf8hvh8ne8g5odl3h0g